DeepMed Research

VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Complete Decongestive Therapy With Negative Pressure for Lipedema and Lymphedema Therapy

Not Applicable

Completed

Conditions: Secondary Lymphedema
Lipedema

Interventions: Other: CDT with graded negative pressure

First Posted Date: 2018-08-16

Last Posted Date: 2020-05-19

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 10

Registration Number: NCT03634462

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Management of Severe Acute Malnutrition in SCD, in Northern Nigeria

Phase 2

Completed

Conditions: Sickle Cell Anemia
Severe Acute Malnutrition

Interventions: Drug: hydroxyurea (20mg/kg/day)
Dietary Supplement: Ready-to-use therapeutic food

First Posted Date: 2018-08-16

Last Posted Date: 2024-03-27

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 132

Registration Number: NCT03634488

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇳🇬
Murtala Mohammad Specialist Hospital, Kano, Nigeria
🇳🇬
Aminu Kano Teaching Hospital, Kano, Nigeria

Pain Outcomes Following Intralesional Corticosteroid Injections

Phase 4

Completed

Conditions: Hypertrophic Scar
Alopecia Areata
Acne
Epidermal Inclusion Cyst
Frontal Fibrosing Alopecia
Keratoacanthoma
Plaque Psoriasis
Keloid
Prurigo Nodularis
Nummular Eczema

Interventions: Drug: Corticosteroid with normal saline
Drug: Corticosteroid with lidocaine

First Posted Date: 2018-08-14

Last Posted Date: 2021-03-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 31

Registration Number: NCT03630198

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease

Not Applicable

Completed

Conditions: Sickle Cell Disease

Interventions: Other: mobile health application

First Posted Date: 2018-08-14

Last Posted Date: 2025-01-14

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 67

Registration Number: NCT03629678

Locations: 🇺🇸
The Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

MR Imaging of Prostatic Calcifications

Withdrawn

Conditions: Prostate Calcification

Interventions: Diagnostic Test: MRI

First Posted Date: 2018-08-10

Last Posted Date: 2020-10-19

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT03625336

Balance in Children With Cochlear Implants

Withdrawn

Conditions: Sensory-Neural Hearing Loss
Balance Disorder
Cochlear Implants

Interventions: Behavioral: Gross motor and developmental balance testing

First Posted Date: 2018-08-08

Last Posted Date: 2024-03-26

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT03620500

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

Phase 2

Active, not recruiting

Conditions: Pulmonary Artery Hypertension

Interventions: Drug: Placebo
Drug: Metformin
Device: mHealth Intervention
Device: Usual Care

First Posted Date: 2018-08-06

Last Posted Date: 2024-10-16

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 73

Registration Number: NCT03617458

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol

Phase 2

Terminated

Conditions: Clostridium Difficile

Interventions: Other: Placebo
Drug: Misoprostol 100Mcg Tab

First Posted Date: 2018-08-06

Last Posted Date: 2022-11-30

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 6

Registration Number: NCT03617172

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States

Safety of LAIV4 in Children With Asthma

Phase 4

Completed

Conditions: Wheezing
Influenza
Asthma in Children
Vaccine Reaction
Asthma
Vaccine Adverse Reaction

Interventions: Biological: Inactivated Influenza Vaccine (IIV)
Biological: Live Attenuated Influenza Vaccine (LAIV)

First Posted Date: 2018-07-26

Last Posted Date: 2021-03-16

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 152

Registration Number: NCT03600428

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Noninvasive Markers of Functional Nausea in Children

Early Phase 1

Active, not recruiting

Conditions: Nausea

Interventions: Diagnostic Test: Questionnaires
Diagnostic Test: 4 channel electrogastrogram (EGG)
Diagnostic Test: 36 channel high resolution electrogastrogram (HR-EGG)
Diagnostic Test: Magnetogastrogram (MGG)
Diagnostic Test: Electrocardiogram (EKG)
Drug: Ondansetron
Drug: Cyproheptadine Oral Tablet

First Posted Date: 2018-07-20

Last Posted Date: 2025-05-30

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 42

Registration Number: NCT03593811

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy